| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/12/2013 | CN103142760A Ginseng Yangyuanbao tablet and preparation method thereof |
| 06/12/2013 | CN103142759A Oral liquid capable of complementing vital essence and tonifying Qi and nourishing blood and tranquilization |
| 06/12/2013 | CN103142740A Chinese herbal medicine mixture for treating abdominal pain and diarrhea and preparation method thereof |
| 06/12/2013 | CN103142721A Method for extracting triterpenoid from anli pear |
| 06/12/2013 | CN103142719A Kidney-tonifying and vitality-culturing prescription |
| 06/12/2013 | CN103142693A Superfine powdery Chinese medicinal preparation for treating allergic rhinitis |
| 06/12/2013 | CN103142685A Method for extraction of total flavonoid aglycones from hickory leaves |
| 06/12/2013 | CN103142680A Heart-nourishing and blood-circulation-promoting prescription |
| 06/12/2013 | CN103142667A Traditional Chinese medicine promoting prescription |
| 06/12/2013 | CN103142666A Health-care composition |
| 06/12/2013 | CN103142662A Method for extracting and purifying polyphenol from choerospondias axillaris peel |
| 06/12/2013 | CN103142661A Preparation method of inonqqus obliquus water-extract fine powder |
| 06/12/2013 | CN103142648A Arsenic compound solution, and alhumin nanoparticles encapsulated with arsenic compound and freeze-drying preparation prepared by same |
| 06/12/2013 | CN103142634A Spirulina phatensis polysaccharide and cynomorium songaricum polysaccharide preparation and manufacture method thereof and application thereof |
| 06/12/2013 | CN103142622A Triamcinolone acetonide and miconazole emulsion type gel |
| 06/12/2013 | CN103142620A Application of ursolic acid to antitumor immunity |
| 06/12/2013 | CN103142600A Weekly administration of dipeptidyl peptidase inhibitors |
| 06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
| 06/12/2013 | CN103142585A Antifungal acne cream |
| 06/12/2013 | CN103142544A Ubenimex capsule composition and preparation method thereof |
| 06/12/2013 | CN103142514A Lyophilized composition for injection containing thymalfasin and preparation method thereof |
| 06/12/2013 | CN103142474A Composition taking high-purity ginkgolide B as active ingredient and preparation method thereof |
| 06/12/2013 | CN103142473A Composition containing high purity bilobalide B and preparation method thereof |
| 06/12/2013 | CN103142472A Ginkgolide B composition and preparation method thereof |
| 06/12/2013 | CN103142468A Tacrolimus eye ointment for cornea transplantation and preparation method thereof |
| 06/12/2013 | CN103141853A Theaflavin health-care food or medicament and preparation method thereof |
| 06/12/2013 | CN102846667B Preparation method for nanometer Periplaneta americana through low temperature drying |
| 06/12/2013 | CN102670456B Multi-effect facial cream and preparation method thereof |
| 06/12/2013 | CN102600228B Method for preparing gypenoside in gypenoside grains |
| 06/12/2013 | CN102440973B Diphenhydramine citrate orally disintegrating tablet and preparation method thereof |
| 06/12/2013 | CN102379838B Method for preparing relaxing and face-cleansing cosmetics and application |
| 06/12/2013 | CN102327462B Traditional Chinese medicine for treating qi and blood insufficiency asthenia diseases of leukemia patients after chemotherapy and method for preparing traditional Chinese medicine preparations |
| 06/12/2013 | CN102309562B Preparation method of taste-masked suspension granules of Gegenqinlian decoction |
| 06/12/2013 | CN102309539B Spina gleditsiae extract hydrogel patch and preparation method thereof |
| 06/12/2013 | CN102166227B Pharmaceutical composition with function of enhancing immunity |
| 06/12/2013 | CN102133250B Medicinal composition with effect of improving immunity |
| 06/12/2013 | CN102090622B Sparassia crispa(Wulf.)Fr. solution preparation method |
| 06/12/2013 | CN102085368B Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating systemic lupus erythematosus |
| 06/12/2013 | CN101932575B Piperidine derivative |
| 06/12/2013 | CN101914135B Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof |
| 06/12/2013 | CN101906418B Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/12/2013 | CN101766299B Immune regulation composite |
| 06/12/2013 | CN101573135B Canine lyme disease vaccine |
| 06/12/2013 | CN101522664B Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione |
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/12/2013 | CN101429184B Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 06/12/2013 | CN101361757B Combination containing brown alga polysaccharide sulfuric ester and propolis and use thereof |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/11/2013 | US8461328 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | US8461139 Oral suspension of prednisolone acetate |
| 06/11/2013 | US8460932 Method of treating a disorder by suicide gene therapy |
| 06/11/2013 | US8460931 Neural progenitor cells derived from embryonic stem cells |
| 06/11/2013 | US8460912 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2683453C Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-.beta.]indoles, methods for the production and use thereof |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/06/2013 | WO2013082503A1 Peptide particle formulation |
| 06/06/2013 | WO2013082394A1 Immunogenic plasmodium falciparum antigen compositions and uses thereof |
| 06/06/2013 | WO2013081143A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/06/2013 | WO2013081016A1 Purinone derivative hydrochloride |
| 06/06/2013 | WO2013080561A1 Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| 06/06/2013 | WO2013079394A1 Increasing the bioavailability of hydroxycinnamic acids |
| 06/06/2013 | WO2013019623A3 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 06/06/2013 | US20130143845 Vitamin d compounds and methods for enhancing muscle strength, and prevention and treatment of disease in human beings |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130142864 In vivo targeting of dendritic cells |
| 06/06/2013 | US20130142817 Microbial delivery system |
| 06/06/2013 | CA2857666A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | CA2857159A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | CA2857150A1 Purinone derivative hydrochloride |
| 06/06/2013 | CA2855566A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/05/2013 | EP2599866A1 Novel nucleic acid having adjuvant activity and use thereof |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2599489A1 AChE antisense deoxyoligonucleotide as an anti-inflammatory agent |
| 06/05/2013 | EP2598631A1 Recombinant bacterium and uses thereof |
| 06/05/2013 | EP2598521A1 Recombinant neisseria meningitidis por a porin proteins |
| 06/05/2013 | EP2598517A1 Modulators of protease activated receptors |
| 06/05/2013 | EP2598500A1 Compositions and methods for inhibition of the jak pathway |
| 06/05/2013 | EP2598493A1 Matrix metalloproteinase inhibitors |
| 06/05/2013 | EP2598477A2 Peripherally restricted faah inhibitors |
| 06/05/2013 | EP2598155A2 Use of blood group status iii |
| 06/05/2013 | CN202961956U Extracting equipment for sheep placenta essence |
| 06/05/2013 | CN202961237U Production equipment for active small molecular sheep placenta extract lyophilized powder |
| 06/05/2013 | CN103140230A Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing diospyros blancoi a. dc. extract as active ingredient |
| 06/05/2013 | CN103140222A Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin |
| 06/05/2013 | CN103131647A Baby bifidobacterium and preparation thereof |
| 06/05/2013 | CN103131607A Ginseng liquor |
| 06/05/2013 | CN103131604A Rheumatism treating nectar |
| 06/05/2013 | CN103131598A Health-care medicinal liquor and preparation method thereof |
| 06/05/2013 | CN103131571A Schisandra chinensis ginseng liquor and preparation method thereof |
| 06/05/2013 | CN103131195A Matsutake active extractives and preparation method and application thereof |
| 06/05/2013 | CN103130907A Chinese cordyceps sinensis protein polysaccharide and preparation and application thereof |
| 06/05/2013 | CN103130865A Sophocarpidine, oxymatrine glycyrrhetinic acid double salt, and preparation method and use thereof |
| 06/05/2013 | CN103130735A Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 06/05/2013 | CN103127500A Application of porphyrin pigment serving as immunologic adjuvant and vaccine |
| 06/05/2013 | CN103127489A Astragali-medlar antimicrobial peptide capsule and preparation process thereof |